Redcare Pharmacy soars after 2025 outlook beats expectations

Redcare Pharmacy NV

11/03/2025 09:10

** Shares in Redcare Pharmacy RDC.DE jump around 16% after better-than-expected outlook

** Group 2025 sales are expected to come in above 3 billion euros ($3.27 billion) vs. an average estimate of 2.93 billion euros according to a company-compiled consensus

** Its full-year adj. EBITDA was 33 million euros vs an estimate of 40.5 million euros

** Intensified marketing efforts for prescriptions brought a strong acceleration of the top line, but hit 2024 profitability, says Jefferies analyst Martin Comtesse

** "However, the guidance for FY25 is a clear positive surprise," Comtesse adds

** Shares will see their best day since May 2022 if gains hold; are at the top of Europe-wide STOXX 600 .STOXX index at 0903 GMT

($1 = 0.9176 euros)

 (Reporting by Isabel Demetz)

 ((Isabel.demetz@thomsonreuters.com))